🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

1,412 notícias encontradas para "research"
Many treatments help chronic back pain, but only in the short term
A large-scale analysis by an international research team, led by Bochum University of Applied Sciences, shows that nonsurgical treatments such as massage, exercise therapy or acupuncture for chronic back pain can alleviate symptoms—but usually only for a few weeks. Clinically sig
DNA damage can trigger neurons to self-destruct
Over the past decade, researchers at WashU Medicine have established that a molecule called SARM1 is a central trigger in the loss of axons, the vital wiring of the nervous system. Axon loss is characteristic of many neurodegenerative diseases, such as amyotrophic lateral scleros
A simple message helps keep stem cell donors on track
A simple message helps keep stem cell donors on track
When a patient needs a stem cell transplant, finding a registered donor is only the first step. Some potential donors drop out before confirmatory typing, reducing the pool from which doctors can choose. Researchers from Osaka University and collaborators tested whether a small c
CAR T cell therapy targets key mutation driving rare blood cancers
CAR T cell therapy targets key mutation driving rare blood cancers
A new form of CAR T-cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells unharmed, according to new research led by UCL and Univers
Novel biomarker beats leading diagnostic blood test at predicting Alzheimer's progression
Small loops of genetic material may be strong indicators of imminent Alzheimer's disease (AD) symptoms. In a new study published in Nature Medicine, researchers showed that elevated levels of certain circular RNAs (circRNAs) in the blood nearly tripled patients' risk of developin
GLP-1 drugs outperform SGLT-2 drugs for patients with Afib and type 2 diabetes
Individuals with atrial fibrillation (Afib), or irregular heart rhythm, are at increased risk of stroke, chronic kidney disease and heart failure. These risks are significantly exacerbated if a type 2 diabetes diagnosis is added to the mix, says Md Mohaimenul Islam, Ph.D., resear
Why 25 minutes may matter in music therapy sessions: Heart-rate synchrony peaks later
New research has discovered the time it takes for a therapist and patient to reach the moment of strongest connection during a therapy session—around 25 minutes. The study, published in the journal Frontiers in Psychology, is the first to identify how long it can take for heart-r
Foto: Jonathan Cooper / Pexels
Fatty liver drives a more dangerous form of colorectal cancer spread, study reveals
Researchers at VIB and KU Leuven, with international partners, have uncovered how fatty liver disease can fuel the most aggressive form of metastatic colorectal cancer. The findings, which appear in the journal Nature, not only explain why some patients face dramatically poorer o
Brain tau spreads differently in early- and late-onset Alzheimer's disease
A new study from Karolinska Institutet has shown that the amount and distribution of the tau protein in the brain differs between early- and late-onset Alzheimer's disease. The results also indicate that blood tests do not always reflect changes in the brain. The research is publ
Foto: Google DeepMind / Pexels
Identification of new molecular markers for multiple myeloma paves path for more precise t
Researchers at Cima and Clinica Universidad de Navarra have identified new molecular mechanisms underlying multiple myeloma. This type of hematologic cancer, which affects the bone marrow, is characterized by its resistance to treatment, leading to relapses in patients. The resea
Discovery could help prevent cancer drug resistance before it starts
Cancer cells are quick to develop resistance to anti-tumor drugs. New research by scientists from the University of California, Davis, shows how cancers adapt to evade a class of anti-tumor drugs called BET inhibitors and offers hope for more effective therapies.
Study identifies new brain targets for individualized epilepsy treatment
Study identifies new brain targets for individualized epilepsy treatment
Mayo Clinic researchers have created a detailed map of the pulvinar, a deep brain region that could help doctors more precisely target brain stimulation therapies for people with drug-resistant epilepsy.